Clinical trial
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for…
NCT00114764 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00114764 |
|---|---|
| Title | Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) |
| Official title | A Multicentre, Double-Blind, Randomised Phase 2 Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | filgrastim, pegfilgrastim |
| Enrollment | 84 |
| Start date | Mar 1, 2003 |
| Primary completion | Apr 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jun 20, 2005 |
| Last update posted | Oct 31, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: